Navigation Links
Hayes, Inc. Releases Guide to BRCA1 and BRCA2 Genetic Testing
Date:5/14/2010

Inappropriate referrals for BRCA1/2 testing drives costs and creates undue anxiety for women.

(PRWEB) May 14, 2010 -- A guide to BRCA1 and BRCA2 genetic testing has been released by Hayes, Inc. This comprehensive resource is designed to equip physicians and other healthcare professionals who are not trained in genetics with independent, evidence-based information to help them understand the complexities of BRCA1/2 gene testing.

According to the American Cancer Society, breast cancer is the most common cancer among American women, except for skin cancers. Women who carry a change in one of the breast cancer susceptibility genes, BRCA1 or BRCA2, have an increased risk of breast and ovarian cancer. Changes in the BRCA1/2 genes can occur in any racial or ethnic group, although in the U.S. they are found most often in Jewish women of Ashkenazi (Eastern Europe) origin. Increasing numbers of women are seeking information concerning their risk of developing breast or ovarian cancer, often with heightened anxiety that has been fueled by direct-to-consumer advertising and information in the social media.

“Knowledge of the genetic basis of a disease has the potential to revolutionize personal healthcare,” says Dr. Diane Allingham-Hawkins, Director, Hayes Genetic Test Evaluation Program. “Unfortunately, however, there is a great deal of misuse of expensive genetic tests due to a lack of understanding of the true clinical utility of these tests. In reality, only 5% of cases of breast or ovarian cancer are caused by these hereditary genetic changes.”

However, the combination of anxiety regarding cancer risk, direct-to-consumer advertising and publicity about the tests, and lack of physician knowledge in the field of genetics has led to inappropriate referrals for women seeing BRCA1 and BRCA2 genetic testing.

“We understand that some of the reasons for these inappropriate referrals are the physician’s concern about upsetting a patient by saying ‘no’ to her request, even though she doesn’t meet the guidelines for testing,” says Dr. Allingham-Hawkins. “However, test results will not provide useful information about cancer risk unless the woman meets these guidelines, and can lead to undue worry without providing any health benefit. In addition, the cost of these tests alone can be greater than $3500, with the recommended genetic counseling adding even more.”

Written in a style that can be understood by both the clinician and non-clinician, the Hayes Guide scrutinizes nearly 300 scientific and clinical publications to provide unbiased information and recommendations regarding BRCA1/2 testing in different patient populations. Included is an in-depth analysis describing each of these tests, with special attention focused on the clinical validity, analytical validity, clinical utility, cost, major payer coverage policies, genetic counseling recommendations, and what the future holds for genetic testing for hereditary breast and ovarian cancer. Generally, access to Hayes genetic test evaluations requires a password-protected subscription to the Hayes Knowledge Center. However, recognizing the importance of this information, Hayes is releasing this special volume for a one-time fee. Click here for more information.

Hayes, Inc. is an independent health technology research and consulting company dedicated to promoting better health outcomes through the use of evidence. The Hayes Genetic Test Evaluation (GTE) program cuts through the “genohype” to the scientific proof regarding the appropriate use of genetic and genomic tests in clinical practice. Currently, there are more than 2000 genetic and genomic tests for inherited and acquired disorders on the market in the United States. With an annual growth rate of 25%, this rapidly growing field has created challenges for healthcare professionals to respond quickly and appropriately to issues related to these tests. Hayes GTE conducts evidence-based assessments with clear, concise conclusions across a range of conditions and applications, including hereditary, cardiovascular, neurological, and developmental disorders, as well as oncology. www.hayesinc.com

Hayes, Inc.: Karen Matthias at 215-855-0615 or kmatthias(at)hayesinc(dot)com

###


Read the full story at http://www.prweb.com/releases/2010/05/prweb4000094.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Hayes, Inc. Technology Prognosis Team Tracks First-of-a-Kind Technologies
2. CerMedia Releases MarinePure High Surface Area Media for Aquatic Biofiltration
3. Premier Literacy Releases Version 12 of the Most Comprehensive Offering of Literacy Tools Available Today
4. Loadstar Sensors Releases LoadVUE-1000 Load Cell Software with Logging, Plotting and Alerting features
5. San Francisco Plastic Surgeon Releases Plastic Surgery Patient Recovery Blog
6. Wyatt Matas & Associates Releases White Paper on Future Home Healthcare Business Model
7. LeveragePoint Releases Complete Online Value Management Solution
8. “You Are Very Pretty”, Says Myeexpert As It Releases A Book, Poetic Expressions, Dedicated To The Beauty of Women.
9. STC Releases iPhone Application to Track Your Immunization Records – MyIR™
10. ASTRO releases SBRT for lung cancer report
11. American Human Development Project Releases 'A Century Apart,' Revealing Alarming Disparities in Well-Being Among U.S. Racial and Ethnic Groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
Breaking Medicine Technology: